Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1995 Feb;71(2):232–239. doi: 10.1038/bjc.1995.49

Activity of interferon alpha, interleukin 6 and insulin in the regulation of differentiation in A549 alveolar carcinoma cells.

C McCormick 1, R I Freshney 1, V Speirs 1
PMCID: PMC2033594  PMID: 7841035

Abstract

The differentiation of A549, a human tumour cell line from type II pneumocytes, can be induced by a crude fibroblast-derived factor (FDF) isolated from the conditioned medium of glucocorticoid-treated lung fibroblasts. In the present report, we have used alkaline phosphatase as a differentiation marker to investigate the activity of a number of growth factors as potential candidates for this paracrine activity. This showed that insulin, interleukin 6 (IL-6), and interferon alpha (IFN-alpha) could simulate the activity of conditioned medium. Their effects were dexamethasone (DX) dependent, additive and reversible with a half-life of 1 week. Transforming growth factor alpha and beta, IL-1 alpha and epidermal growth factor, were all inhibitory, and inhibition was opposed, partially or completely, by DX. The most potent inducer was IL-6, but as DX was shown to decrease the concentration of IL-6 in lung fibroblast-conditioned medium it seems an unlikely candidate for FDF. Unlike FDF, all of the positive-acting factors were shown to induce plasminogen activator. FDF has also been shown to be active in the absence of DX. This suggests that differentiation-inducing activity may be present in several paracrine factors, but that so far a candidate for FDF has not been identified.

Full text

PDF
237

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams E. F., Rafferty B., White M. C. Interleukin 6 is secreted by breast fibroblasts and stimulates 17 beta-oestradiol oxidoreductase activity of MCF-7 cells: possible paracrine regulation of breast 17 beta-oestradiol levels. Int J Cancer. 1991 Aug 19;49(1):118–121. doi: 10.1002/ijc.2910490122. [DOI] [PubMed] [Google Scholar]
  2. Bond J. A., Graham G. J., Freshney M., Dawson T., Sawhney N., Williams E. D., Wynford-Thomas D. Detection and partial purification of a potent mitogenic factor for human thyroid follicular cells. Mol Cell Endocrinol. 1992 Mar;84(1-2):R15–R21. doi: 10.1016/0303-7207(92)90086-l. [DOI] [PubMed] [Google Scholar]
  3. Cunha G. R., Chung L. W., Shannon J. M., Taguchi O., Fujii H. Hormone-induced morphogenesis and growth: role of mesenchymal-epithelial interactions. Recent Prog Horm Res. 1983;39:559–598. doi: 10.1016/b978-0-12-571139-5.50018-5. [DOI] [PubMed] [Google Scholar]
  4. Cunha G. R., Young P. Role of stroma in oestrogen-induced epithelial proliferation. Epithelial Cell Biol. 1992 Jan;1(1):18–31. [PubMed] [Google Scholar]
  5. Edelson J. D., Shannon J. M., Mason R. J. Alkaline phosphatase: a marker of alveolar type II cell differentiation. Am Rev Respir Dis. 1988 Nov;138(5):1268–1275. doi: 10.1164/ajrccm/138.5.1268. [DOI] [PubMed] [Google Scholar]
  6. Egorin M. J., Sigman L. M., Van Echo D. A., Forrest A., Whitacre M. Y., Aisner J. Phase I clinical and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered as a five-day continuous infusion. Cancer Res. 1987 Jan 15;47(2):617–623. [PubMed] [Google Scholar]
  7. Eicher D. J., Moats-Staats B. M., Stiles A. D., D'Ercole A. J. Possible autocrine/paracrine actions of insulin-like growth factors during embryonic development: expression and action of IGFs in undifferentiated P19 cells. Dev Genet. 1993;14(3):194–203. doi: 10.1002/dvg.1020140306. [DOI] [PubMed] [Google Scholar]
  8. Gaben-Cogneville A. M., Breant B., Coudray A. M., Hoa D. H., Mester J. Differentiation of newborn rat preadipocytes in culture: effects of insulin and dexamethasone. Exp Cell Res. 1990 Nov;191(1):133–140. doi: 10.1016/0014-4827(90)90046-d. [DOI] [PubMed] [Google Scholar]
  9. Giard D. J., Aaronson S. A., Todaro G. J., Arnstein P., Kersey J. H., Dosik H., Parks W. P. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst. 1973 Nov;51(5):1417–1423. doi: 10.1093/jnci/51.5.1417. [DOI] [PubMed] [Google Scholar]
  10. Jacobs A. L., Sehgal P. B., Julian J., Carson D. D. Secretion and hormonal regulation of interleukin-6 production by mouse uterine stromal and polarized epithelial cells cultured in vitro. Endocrinology. 1992 Sep;131(3):1037–1046. doi: 10.1210/endo.131.3.1505448. [DOI] [PubMed] [Google Scholar]
  11. Jessell T. M., Melton D. A. Diffusible factors in vertebrate embryonic induction. Cell. 1992 Jan 24;68(2):257–270. doi: 10.1016/0092-8674(92)90469-s. [DOI] [PubMed] [Google Scholar]
  12. Klagsbrun M., Baird A. A dual receptor system is required for basic fibroblast growth factor activity. Cell. 1991 Oct 18;67(2):229–231. doi: 10.1016/0092-8674(91)90173-v. [DOI] [PubMed] [Google Scholar]
  13. Kohlhepp E. A., Condon M. E., Hamburger A. W. Recombinant human interferon alpha enhancement of retinoic-acid-induced differentiation of HL-60 cells. Exp Hematol. 1987 May;15(4):414–418. [PubMed] [Google Scholar]
  14. Lieber M., Smith B., Szakal A., Nelson-Rees W., Todaro G. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer. 1976 Jan 15;17(1):62–70. doi: 10.1002/ijc.2910170110. [DOI] [PubMed] [Google Scholar]
  15. López-Casillas F., Cheifetz S., Doody J., Andres J. L., Lane W. S., Massagué J. Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system. Cell. 1991 Nov 15;67(4):785–795. doi: 10.1016/0092-8674(91)90073-8. [DOI] [PubMed] [Google Scholar]
  16. Mackie A. E., Freshney R. I., Akturk F., Hunt G. Glucocorticoids and the cell surface of human glioma cells: relationship to cytostasis. Br J Cancer Suppl. 1988 Dec;9:101–107. [PMC free article] [PubMed] [Google Scholar]
  17. McLean J. S., Frame M. C., Freshney R. I., Vaughan P. F., Mackie A. E., Singer I. Phenotypic modification of human glioma and non-small cell lung carcinoma by glucocorticoids and other agents. Anticancer Res. 1986 Sep-Oct;6(5):1101–1106. [PubMed] [Google Scholar]
  18. Meyskens F. L., Jr Retinoids as anticancer agents. J Clin Oncol. 1993 Mar;11(3):588–589. doi: 10.1200/JCO.1993.11.3.588. [DOI] [PubMed] [Google Scholar]
  19. Post M., Floros J., Smith B. T. Inhibition of lung maturation by monoclonal antibodies against fibroblast-pneumonocyte factor. Nature. 1984 Mar 15;308(5956):284–286. doi: 10.1038/308284a0. [DOI] [PubMed] [Google Scholar]
  20. Quinn L. S., Ong L. D., Roeder R. A. Paracrine control of myoblast proliferation and differentiation by fibroblasts. Dev Biol. 1990 Jul;140(1):8–19. doi: 10.1016/0012-1606(90)90048-n. [DOI] [PubMed] [Google Scholar]
  21. Rusnati M., Urbinati C., Presta M. Internalization of basic fibroblast growth factor (bFGF) in cultured endothelial cells: role of the low affinity heparin-like bFGF receptors. J Cell Physiol. 1993 Jan;154(1):152–161. doi: 10.1002/jcp.1041540119. [DOI] [PubMed] [Google Scholar]
  22. Smith B. T., Fletcher W. A. Pulmonary epithelial-mesenchymal interactions: beyond organogenesis. Hum Pathol. 1979 May;10(3):248–250. doi: 10.1016/s0046-8177(79)80020-9. [DOI] [PubMed] [Google Scholar]
  23. Speirs V., Ray K. P., Freshney R. I. Paracrine control of differentiation in the alveolar carcinoma, A549, by human foetal lung fibroblasts. Br J Cancer. 1991 Oct;64(4):693–699. doi: 10.1038/bjc.1991.383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Stockdale F. E., Topper Y. J. The role of DNA synthesis and mitosis in hormone-dependent differentiation. Proc Natl Acad Sci U S A. 1966 Oct;56(4):1283–1289. doi: 10.1073/pnas.56.4.1283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Takahashi K., Suzuki K., Kawahara S., Ono T. Effects of lactogenic hormones on morphological development and growth of human breast epithelial cells cultivated in collagen gels. Jpn J Cancer Res. 1991 May;82(5):553–558. doi: 10.1111/j.1349-7006.1991.tb01886.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Torday J. S., Kourembanas S. Fetal rat lung fibroblasts produce a TGF beta homolog that blocks alveolar type II cell maturation. Dev Biol. 1990 May;139(1):35–41. doi: 10.1016/0012-1606(90)90276-o. [DOI] [PubMed] [Google Scholar]
  27. Ward F. T., Kelley J. A., Roth J. S., Lombardo F. A., Weiss R. B., Leyland-Jones B., Chun H. G. Phase I bioavailability and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered via nasogastric tube. Cancer Res. 1991 Apr 1;51(7):1803–1810. [PubMed] [Google Scholar]
  28. Whur P., Magudia M., Boston J., Lockwood J., Williams D. C. Plasminogen activator in cultured Lewis lung carcinoma cells measured by chromogenic substrate assay. Br J Cancer. 1980 Aug;42(2):305–313. doi: 10.1038/bjc.1980.231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Wuarin L., Verity M. A., Sidell N. Effects of interferon-gamma and its interaction with retinoic acid on human neuroblastoma differentiation. Int J Cancer. 1991 Apr 22;48(1):136–141. doi: 10.1002/ijc.2910480124. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES